摘要
Abstract
The 6+1 dimension clinical comprehensive evaluation of Ganjie Bingmei tablet in the treatment of acute pharyngitis was carried out.Safety evaluation showed that Ganjie Bingmei tablet had few adverse reactions in clinical use,which could ensure drug safety,and was rated as grade A;Systematic evaluation of effectiveness showed that Ganjie Bingmei tablet had better clinical effectiveness than Qingyan dripping pill in the treatment of acute pharyngitis(P＜0.000 01),Ganjie Bingmei tablet had better efficacy than Ganjie Qingyan granule in the treatment of acute pharyngitis(syndrome of wind-heat attacking lung)(P＜0.05),and was rated as grade A.Economic research shows that compared with Qingyan dripping pills and Ganjie Qingyan granule,Ganjie Bingmei tablet has lower cost and is an ab-solute advantage program,rated as grade A;Ganjie Bingmei tablet has sufficient data in clinical innovation and industrial innovation,and its innovation is rated as B grade;The Ganjie Bingmei tablet meets the technical requirements,has good suitability,and is rated as grade A;The prescription restriction is small,the medicinal material resources are sustainable,the price is at the low level of the pharyngeal proprietary Chinese medicine in the basic medicine list and the medical insurance list,and the accessibility is good,and it is rated as grade A;Ganjie Bingmei tablet formula comes from the famous prescription"Qingyin pill",which matches the pathogenesis characteris-tics of wind-heat attacking lung.The total number of cases studied after listing has more than 2000 cases,and the characteristics of tradi-tional Chinese medicine are prominent,and it is rated as grade A.Comprehensive evaluation of clinical value indicates that the clinical value of Ganjie Bingmei tablet is sufficient,and the result is confirmed.关键词
甘桔冰梅片/急性咽炎/安全性/有效性/临床综合评价Key words
Ganjie Bingmei tablet/Acute pharyngitis/Security/Effectiveness/Clinical comprehensive evaluation分类
医药卫生
